查看購物車
  • English
  • Japanese
  • Korean
電腦斷層掃描（CT）市場—全球及區域分析：按類型、技術、最終用戶和地區分類—分析與預測（2026-2036 年）
市場調查報告書
商品編碼
2055558

電腦斷層掃描（CT）市場—全球及區域分析：按類型、技術、最終用戶和地區分類—分析與預測（2026-2036 年）

Computed Tomography Market - A Global and Regional Analysis: Type, Technology, End User, and Regional Analysis - Analysis and Forecast, 2026-2036
出版日期: | 出版商: BIS Research | 英文 176 Pages | 商品交期: 1-5個工作天內

價格

預計到 2025 年，全球電腦斷層掃描 (CT) 市場規模將達到 73.974 億美元，並有望顯著成長。

預計到 2036 年，該產業規模將飆升至 131.971 億美元，在 2026 年至 2036 年期間的年複合成長率將達到驚人的 5.47%。

關鍵市場統計數據
預測期 2026-2036
2026年市場規模 77.462億美元
2036 年預測 131.971億美元
年複合成長率 5.47%

全球電腦斷層掃描 (CT) 市場正經歷強勁成長，這主要得益於患者數量的增加和放射科工作流程壓力的增大，從而導致對更快、更準確、更擴充性的診斷成像的需求日益成長。 CT 是醫療保健系統中一項至關重要的影像技術，尤其是在急診醫學、腫瘤學、心臟病學和神經病學領域，快速且準確的斷層影像對於臨床決策至關重要。慢性疾病負擔的加重，加上電腦斷層掃描量的增加以及在急診和預防保健路徑中應用範圍的擴大，進一步強化了 CT 在醫院和影像中心的作用。將人工智慧 (AI) 整合到 CT 工作流程中，透過實現高級影像重建、自動檢測、工作流程優先排序和臨床決策支持，正在變革傳統的成像方式。在創傷治療、中風評估和癌症診斷等高容量、時間緊迫的環境中，CT 系統尤其有價值，因為在這些環境中，快速分流和準確的影像解讀至關重要。隨著醫療保健系統向基於價值的護理和營運效率轉變，先進 CT 技術的應用正在加速，以提高診斷一致性、縮短測試結果返回時間並最佳化資源利用。

成像硬體和計算演算法的技術進步顯著提升了CT的性能。多切面CT、雙源CT、頻譜成像、光子計數檢測器以及人工智慧重建等創新技術，提高了影像質量，簡化了組織表徵，並降低了輻射曝射量。此外，CT系統與包括PACS、RIS和雲端平台在內的數位醫療基礎設施的整合，實現了跨多站點醫療網路的可擴展部署，支援無縫資料共用和遠距離診斷。對企業級成像和整合工作流程解決方案的日益重視，進一步推動了從獨立成像系統向互聯的、以工作流程為中心的平台的轉變。然而，市場仍面臨許多挑戰，例如高昂的資本投資和生命週期成本、輻射暴露問題、複雜的監管以及互通性問題。儘管存在這些挑戰，但醫療基礎設施投資的增加、診斷成像網路的擴展以及成像設備供應商和技術提供者之間的策略合作，預計將推動電腦斷層掃描（CT）市場的持續成長和創新。

市場概覽

由於技術的不斷進步以及人工智慧 (AI) 在診斷影像工作流程中日益廣泛的應用，全球電腦斷層掃描 (CT) 市場正經歷著顯著的變革。各公司正逐步將 AI 功能整合到其 CT 系統中，以增強影像重建、實現自動化檢測並提高工作流程效率。這些創新支持廣泛的臨床應用，包括腫瘤學、心臟病學、神經病學和急診影像，從而帶來更快、更準確、更標準化的診斷結果。

頻譜成像、光子計數CT、高切系統和人工智慧驅動的重建演算法等關鍵技術的進步，凸顯了業界致力於提升影像品質、降低輻射曝射量和提高診斷準確性的決心。此外，CT系統與企業級影像平台（包括PACS、RIS和雲端解決方案）的整合，正在加強整個醫療環境中的互通性、資料共用和臨床決策支援。

對快速診斷的需求日益成長、影像檢查檢查數量的增加以及對疾病早期檢測的日益重視，正進一步加速CT在已開發市場和新興市場的應用。隨著醫療系統不斷優先考慮效率、準確性和患者療效，電腦斷層掃描（CT）技術的持續創新有望在塑造未來診斷影像和臨床工作流程方面發揮關鍵作用。

對產業的影響

全球電腦斷層掃描（CT）市場正經歷顯著成長，其驅動力包括對高精度診斷影像日益成長的需求、影像檢查數量的增加以及對高效且擴充性的放射科工作流程的需求。佳能公司、Carestream Health Inc.、西門子醫療股份公司、富士膠片控股株式會社、通用電氣醫療集團、皇家飛利浦公司、Koning Health、NeuroLogica Corp.、東軟集團、深圳安科高新技術有限公司、上海聯影醫療股份有限公司、Planmed Oy、VATECH 和 Xoran Technologies 等領先企業正推動著新戰略投資和戰略投資至關重要的戰略。

這些公司正積極致力於開發和整合先進技術，例如人工智慧驅動的診斷成像、頻譜和光子計數CT以及低劑量系統，這些技術正在變革診斷能力並加速技術升級週期，尤其是在成熟市場。這些創新正在提高影像質量，增強診斷信心，並使腫瘤學、心臟病學和神經病學等臨床領域的疾病檢測更加精準。

同時，在新興市場需求不斷成長的推動下，製造商正致力於開發經濟高效、擴充性且模組化的CT系統，以適應資源有限的環境，從而擴大先進診斷成像技術的普及範圍。診斷影像公司、人工智慧解決方案供應商和醫療機構之間的策略合作，進一步促進了創新和市場擴張。

此外，CT系統與包括PACS、RIS和雲端平台在內的數位醫療基礎設施的整合，簡化了工作流程，實現了遠距離診斷，並支援數據驅動的臨床決策。總體而言，CT系統正在提高診斷準確性，縮短檢測結果返回時間，並改善患者預後，同時推動整個醫學影像和醫療保健生態系統的更廣泛變革。

目錄

第1章：全球電腦斷層掃描（CT）市場：產業展望

  • 市場概覽
    • 市場概覽與生態系統
    • 供應鏈分析
    • 價值鏈分析
  • 市場趨勢
    • 影響分析
  • 監理情勢
    • 北美洲
    • 北美洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場動態
    • 促進因素、挑戰和機會：當前和未來影響評估
    • 市場促進因素
    • 市場限制因素
    • 市場機遇

第2章 類型

  • 概述
    • 固定式CT掃描儀
    • 可攜式CT掃描儀

第3章 技術

  • 概述
    • 高切CT
    • 中切CT
    • 低切CT
    • 錐狀射束CT（CBCT）

第4章 最終用戶

  • 概述
    • 醫院及門診手術中心
    • 診斷中心
    • 其他

第5章 區域

  • 區域概況
  • 北美洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
    • 美國
      • 國家概況
      • 市場規模及預測
    • 加拿大
      • 國家概況
      • 市場規模及預測
  • 歐洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
    • 英國
      • 國家概況
      • 市場規模及預測
    • 德國
      • 國家概況
      • 市場規模及預測
    • 法國
      • 國家概況
      • 市場規模及預測
    • 義大利
      • 國家概況
      • 市場規模及預測
    • 西班牙
      • 國家概況
      • 市場規模及預測
    • 其他歐洲國家
      • 國家概況
      • 市場規模及預測
  • 亞太地區
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
    • 中國
      • 國家概況
      • 市場規模及預測
    • 日本
      • 國家概況
      • 市場規模及預測
    • 印度
      • 國家概況
      • 市場規模及預測
    • 澳洲
      • 國家概況
      • 市場規模及預測
    • 韓國
      • 國家概況
      • 市場規模及預測
    • 亞太其他地區
      • 國家概況
      • 市場規模及預測
  • 拉丁美洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
    • 巴西
      • 國家概況
      • 市場規模及預測
    • 墨西哥
      • 國家概況
      • 市場規模及預測
    • 其他拉丁美洲
      • 國家概況
      • 市場規模及預測
  • 中東和非洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
    • 土耳其
      • 國家概況
      • 市場規模及預測
    • 以色列
      • 國家概況
      • 市場規模及預測
    • 其他中東和非洲地區
      • 國家概況
      • 市場規模及預測

第6章：競爭標竿分析與公司概況

  • 關鍵策略與趨勢（2020-2026）
  • 主要發展分析（依公司分類），2024-2026 年
  • 公司簡介
    • Canon Inc.
    • Carestream Health
    • Siemens Healthineers AG
    • GE HealthCare
    • FUJIFILM Corporation
    • Koninklijke Philips NV
    • Koning Health
    • NeuroLogica Corp.
    • Neusoft Corporation
    • Shenzhen Anke High-tech Co., Ltd
    • Shanghai United Imaging Healthcare Co., Ltd.
    • Planmed Oy
    • VATECH
    • Xoran Technologies

第7章：調查方法

Product Code: BHR1770SB

This report can be delivered within 1 working day.

Introduction of the Computed Tomography Market

The global computed tomography market, initially valued at $7,397.4 million in 2025, is projected to witness substantial growth, surging to $13,197.1 million by 2036, marking a remarkable compound annual growth rate (CAGR) of 5.47% over the period from 2026 to 2036.

KEY MARKET STATISTICS
Forecast Period2026 - 2036
2026 Evaluation$7,746.2 Million
2036 Forecast$13,197.1 Million
CAGR5.47%

The global computed tomography market is witnessing robust growth, driven by the increasing demand for faster, more accurate, and scalable diagnostic imaging amid rising patient volumes and growing pressure on radiology workflows. Computed tomography has become a critical imaging modality across healthcare systems, particularly in emergency care, oncology, cardiology, and neurology, where rapid and precise cross-sectional imaging is essential for clinical decision-making. The rising burden of chronic diseases, along with increasing CT scan volumes and expanding use in acute and preventive care pathways, is further strengthening the role of CT across hospitals and diagnostic imaging centers. The integration of artificial intelligence into CT workflows is transforming conventional imaging by enabling advanced image reconstruction, automated detection, workflow prioritization, and clinical decision support. CT systems are particularly valuable in high-volume and time-sensitive settings such as trauma care, stroke evaluation, and cancer diagnosis, where rapid triage and accurate interpretation are critical. As healthcare systems shift toward value-based care and operational efficiency, the adoption of advanced CT technologies is accelerating to improve diagnostic consistency, reduce turnaround times, and optimize resource utilization.

Technological advancements in imaging hardware and computational algorithms are significantly enhancing CT capabilities. Innovations such as multi-slice and dual-source systems, spectral imaging, photon-counting detectors, and AI-enabled reconstruction are improving image quality, enabling better tissue characterization, and reducing radiation dose. In addition, the integration of CT systems with digital health infrastructure, including PACS, RIS, and cloud-based platforms, is enabling scalable deployment across multi-site healthcare networks and supporting seamless data sharing and remote diagnostics. The growing emphasis on enterprise imaging and integrated workflow solutions is further driving the transition from standalone imaging systems to connected, workflow-centric platforms. However, the market continues to face challenges, including high capital investment and lifecycle costs, radiation exposure concerns, regulatory complexities, and interoperability issues. Despite these challenges, increasing investments in healthcare infrastructure, expansion of diagnostic imaging networks, and strategic collaborations among imaging vendors and technology providers are expected to drive sustained growth and innovation in the computed tomography market.

Market Introduction

The global computed tomography (CT) market has undergone a notable transformation, driven by continuous technological advancements and increasing integration of artificial intelligence into imaging workflows. Companies are progressively embedding AI-enabled capabilities into CT systems to enhance image reconstruction, automate detection, and improve workflow efficiency. These innovations support a wide range of clinical applications, including oncology, cardiology, neurology, and emergency imaging, enabling faster, more accurate, and standardized diagnostic outcomes.

Key advancements, such as spectral imaging, photon-counting CT, high-slice systems, and AI-driven reconstruction algorithms, highlight the industry's focus on improving image quality, reducing radiation dose, and increasing diagnostic precision. Additionally, the integration of CT systems with enterprise imaging platforms, including PACS, RIS, and cloud-based solutions, is enhancing interoperability, data sharing, and clinical decision support across healthcare settings.

The growing demand for rapid diagnostics, rising imaging volumes, and increasing focus on early disease detection are further accelerating CT adoption across both developed and emerging markets. As healthcare systems continue to prioritize efficiency, accuracy, and patient outcomes, ongoing innovations in computed tomography are expected to play a critical role in shaping the future of diagnostic imaging and clinical workflows.

Industrial Impact

The global computed tomography (CT) market has witnessed substantial growth, driven by the increasing demand for high-accuracy diagnostic imaging, rising imaging volumes, and the need for efficient and scalable radiology workflows. Key players such as Canon Inc., Carestream Health Inc., Siemens Healthineers AG, FUJIFILM Holdings Corporation, GE HealthCare, Koninklijke Philips N.V., Koning Health, NeuroLogica Corp., Neusoft Corporation, Shenzhen Anke High-tech Co., Ltd., Shanghai United Imaging Healthcare Co., Ltd., Planmed Oy, VATECH, and Xoran Technologies are playing a pivotal role in advancing CT technologies through continuous innovation and strategic investments.

These companies are actively focusing on the development and integration of advanced technologies, including AI-enabled imaging, spectral and photon-counting CT, and low-dose systems, which are transforming diagnostic capabilities and accelerating technology upgrade cycles, particularly in mature markets. Such innovations are enhancing image quality, improving diagnostic confidence, and enabling more precise disease detection across clinical areas such as oncology, cardiology, and neurology.

At the same time, increasing demand from emerging markets is encouraging manufacturers to develop cost-effective, scalable, and modular CT systems tailored to resource-constrained settings, thereby expanding access to advanced imaging. Strategic collaborations between imaging companies, AI solution providers, and healthcare institutions are further supporting innovation and market expansion.

Additionally, the integration of CT systems with digital health infrastructure, including PACS, RIS, and cloud-based platforms, is improving workflow efficiency, enabling remote diagnostics, and supporting data-driven clinical decision-making. Overall, CT systems are enhancing diagnostic accuracy, reducing turnaround times, and improving patient outcomes, while also driving broader transformation across the medical imaging and healthcare ecosystem.

Market Segmentation

Segmentation 1: By Type

  • Stationary CT Scanners
  • Portable CT Scanners

Stationary CT Scanners to Dominate the Computed Tomography Market (by Type)

In terms of type, the stationary CT scanners segment is expected to lead the computed tomography market, accounting for a significant share due to its widespread deployment across hospitals and diagnostic imaging centers. These systems offer advanced imaging capabilities, including high-slice configurations, faster scan speeds, and broader clinical applications such as cardiology, oncology, and trauma care. Their ability to support high patient throughput and seamless integration with hospital IT systems further reinforces their market dominance.

Segmentation 2: By Technology

  • High-Slice CT
  • Mid-Slice CT
  • Low-Slice CT
  • Cone Beam CT

High-Slice CT to Dominate the Computed Tomography Market (by Technology)

In terms of technology, high-slice CT is expected to lead the global computed tomography market, driven by its advanced imaging capabilities, faster scan speeds, and superior diagnostic accuracy. These systems are widely adopted in developed healthcare settings for complex applications such as cardiology, oncology, and trauma imaging, where precision and speed are critical. Their ability to support high patient throughput and integrate with advanced software solutions further strengthens their adoption across high-volume clinical environments.

Segmentation 3: By End User

  • Hospitals and Ambulatory Surgery Centers
  • Diagnostic Centers
  • Others

Hospitals and Ambulatory Surgery Centers to Dominate the Computed Tomography Market (by End User)

In terms of end users, hospitals and ambulatory surgery centers are expected to lead the global computed tomography market, growing at a CAGR of 4.89%, driven by their high patient volumes, comprehensive care capabilities, and access to advanced imaging infrastructure. These facilities typically handle complex and emergency cases, requiring high-performance CT systems for applications such as trauma, oncology, and cardiovascular imaging. Additionally, strong capital budgets and integration with hospital IT systems further support the dominance of this segment.

Segmentation 4: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa
    • Turkey
    • Israel
    • Rest-of-Middle East and Africa

North America to Dominate the Computed Tomography Market (by Region)

North America is expected to lead the global computed tomography market, supported by a highly mature U.S. market and a relatively capacity-constrained Canadian market. The U.S. benefits from a high installed base, strong replacement cycles, and advanced imaging infrastructure, positioning it among the most CT-intensive markets globally, while Canada operates with comparatively lower scanner availability and more centralized infrastructure, creating opportunities for capacity expansion and improved access.

The region also benefits from widespread integration of electronic health records (EHRs), PACS, and RIS systems, enabling efficient workflow management, seamless image sharing, and effective adoption of advanced CT technologies across hospitals and diagnostic imaging centers. Utilization levels remain consistently high, with strong procedural volumes across emergency, inpatient, and outpatient settings in the U.S., and high-efficiency system usage in Canada despite infrastructure limitations.

Recent Developments in the Computed Tomography Market

  • In Jan 2026, Planmed Oy announced that its Planmed Verity XFI weight-bearing CT scanner received CE marking under the European Union Medical Device Regulation (EU MDR).
  • In May 2025, FUJIFILM Corporation received FDA 510(k) clearance for an updated version of the SCENARIA View CT system, incorporating advanced workflow and automation enhancements. Key updates include AutoPose, an AI-based positioning tool that automatically identifies anatomical regions from localization images and sets optimal scan and reconstruction ranges, and RemoteRecon, which enables reconstruction parameter processing on an external workstation connected to the CT system.
  • In June 2024, FUJIFILM Corporation launched FCT iStream, a compact 128-slice CT system, and said it was designed for the hospital and outpatient market. The company highlighted four proprietary technologies-HiMAR Plus, Intelli IPV, SynergyDrive, and IntelliODM to improve image sharpness, streamline workflow through AI automation, and reduce patient dose.

Demand - Drivers, Challenges, and Opportunities

Market Drivers

Rising Disease Burden and Increasing CT Scan Volumes Driving Demand for CT Scanners: The global demand for computed tomography (CT) scanners is strongly driven by the rising burden of chronic diseases and the corresponding increase in CT scan volumes across healthcare systems. According to the World Health Organization, nearly 20 million new cancer cases were reported in 2022, with projections expected to reach approximately 35 million by 2050, highlighting the growing need for advanced diagnostic imaging. CT plays a critical role in early detection, staging, and monitoring across oncology, cardiology, neurology, and emergency care, particularly as cardiovascular diseases remain the leading cause of global mortality. The expansion of emergency and trauma care services is further increasing CT utilization, given its importance in rapid clinical decision-making. At the same time, advancements in multi-slice CT systems, faster acquisition speeds, and improved image quality are enabling higher patient throughput, supporting increased scan volumes. The integration of CT into routine clinical workflows, including preventive screening programs such as low-dose CT for lung cancer, is also driving repeat imaging and longitudinal monitoring. Additionally, demographic factors such as aging populations and urbanization, along with improving healthcare infrastructure in emerging markets, are expanding access and utilization, collectively reinforcing sustained demand for high-performance CT systems globally.

Market Restraints

High Capital Investment and Lifecycle Costs Associated with CT Systems: The high capital investment and ongoing lifecycle costs associated with computed tomography (CT) systems remain a major restraint to market adoption, particularly in cost-sensitive healthcare settings. CT scanners require significant upfront investment, typically ranging from approximately $285,000-$360,000 for 16-slice systems to over $1.3 million-$2.1 million for advanced 256+ slice configurations, in addition to substantial installation costs related to site preparation, radiation shielding, cooling systems, and infrastructure upgrades. Beyond acquisition, recurring expenses such as annual service contracts, often between $70,000 and $150,000, along with costs for maintenance, component replacements (e.g., X-ray tubes and detectors), and software upgrades, further increase the total cost of ownership. Rapid technological advancements, including AI integration, spectral imaging, and dose optimization features, are also shortening upgrade cycles, compelling providers to invest in newer systems to remain competitive. Additionally, ongoing regulatory compliance, quality assurance, and certification requirements add to operational expenditures, collectively creating financial constraints that can delay procurement decisions and limit adoption, especially in emerging markets.

Market Opportunities

Expansion of CT Access in Emerging and Underserved Markets: A significant opportunity in the computed tomography (CT) market lies in expanding access across emerging and underserved regions, where imaging infrastructure remains limited. Many low- and middle-income countries continue to face gaps in the availability of CT systems, leading to delayed diagnosis and treatment of critical conditions such as cancer, cardiovascular diseases, and trauma. Improving access to CT imaging in these regions can significantly enhance early detection, clinical outcomes, and overall healthcare efficiency. This opportunity is further supported by increasing healthcare investments, government initiatives, and efforts to strengthen diagnostic capabilities across Asia-Pacific, the Middle East, and Africa. Vendors that offer cost-effective systems, mobile CT solutions, and flexible service models are well-positioned to address these unmet needs and capture growth in these high-potential markets.

How can this report add value to an organization?

Product/Innovation Strategy: The global computed tomography market has been divided into several key segments, including type, technology, end users, and regional markets. By understanding which segments hold the largest share and which ones show potential for growth, this report offers invaluable insights for organizations looking to innovate and expand their product offerings.

Growth/Marketing Strategy: Strategic partnerships, collaborations, and business expansions are anticipated to be central to the growth of the computed tomography market. Key developments and partnerships among diagnostic companies, healthcare providers, and research institutions have already begun to form a significant part of the market dynamics.

Competitive Strategy: The computed tomography market is highly competitive, with numerous well-established players offering computed tomography systems. Key market participants are actively focusing on technological innovation, including the integration of artificial intelligence, photon-counting CT, spectral imaging, and low-dose technologies, to differentiate their offerings.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2036 have been considered for the global market size estimation, 2025 has been considered as the base year, and 2026 to 2036 as the forecast period.
  • The scope of the report is based on comprehensive inputs from industry experts across various sectors, including specialty clinics and hospitals, diagnostic laboratories, imaging centers, reference laboratories, and research institutions.
  • The market contribution of computed tomography is anticipated to grow substantially in the future, with projections based on historical analysis of available solutions.
  • Revenues from companies have been sourced from their annual reports for FY2024 and FY2025. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The market has been mapped based on the existing computed tomography systems. Key companies with significant offerings in this field have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts and key stakeholders across the healthcare and computed tomography (CT) ecosystem, including CT system manufacturers, advanced imaging technology providers, radiology service providers, and healthcare institutions. Stakeholders such as hospitals, diagnostic imaging centers, academic and research institutes, and teleradiology providers have been consulted to validate adoption trends, workflow integration, and clinical utility specific to CT imaging. Respondents, including CEOs, vice presidents, product and marketing directors, radiologists, and technology and innovation leaders, have been interviewed to obtain and verify both qualitative and quantitative insights for this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles

Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Canon Inc.
  • Carestream Health Inc.
  • Siemens Healthineers AG
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Koninklijke Philips N.V.
  • Koning Health
  • NeuroLogica Corp.
  • Neusoft Corporation
  • Shenzhen Anke High-tech Co., Ltd
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Planmed Oy
  • VATECH
  • Xoran Technologies

Table of Contents

Executive Summary

Scope and Definition

1 Global Computed Tomography Market: Industry Outlook

  • 1.1 Market Overview
    • 1.1.1 Market Overview and Ecosystem
    • 1.1.2 Supply Chain Analysis
    • 1.1.3 Value Chain Analysis
  • 1.2 Market Trends
    • 1.2.1 Impact Analysis
      • 1.2.1.1 Increasing Product Approval by Regulatory Authorities Leading to Advanced, AI-Driven, and Specialty CT Offerings
      • 1.2.1.2 Increasing Strategic Partnerships and Alliances Driving Market Expansion and Technology Adoption in CT Systems
  • 1.3 Regulatory Landscape
    • 1.3.1 North America
      • 1.3.1.1 U.S.
      • 1.3.1.2 Canada
    • 1.3.2 Europe
      • 1.3.2.1 EU Countries
      • 1.3.2.2 U.K.
    • 1.3.3 Asia-Pacific
      • 1.3.3.1 Japan
      • 1.3.3.2 China
      • 1.3.3.3 India
    • 1.3.4 Latin America
      • 1.3.4.1 Brazil
      • 1.3.4.2 Mexico
    • 1.3.5 Middle East and Africa
      • 1.3.5.1 Turkey
      • 1.3.5.2 Israel
  • 1.4 Market Dynamics
    • 1.4.1 Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
    • 1.4.2 Market Drivers
      • 1.4.2.1 Rising Disease Burden and Increasing CT Scan Volumes Driving Demand for CT Scanners
      • 1.4.2.2 Increasing Focus on Early Diagnosis and Preventive Screening Driving CT Adoption
      • 1.4.2.3 Advancements in CT Imaging Technologies Driving Clinical Adoption 3D and 4D Imaging
    • 1.4.3 Market Restraints
      • 1.4.3.1 High Capital Investment and Lifecycle Costs Associated with CT Systems
      • 1.4.3.2 Radiation Exposure Concerns and Regulatory Constraints
    • 1.4.4 Market Opportunities
      • 1.4.4.1 Expansion of CT Access in Emerging and Underserved Markets

2 Type

  • 2.1 Overview
    • 2.1.1 Stationary CT Scanners
    • 2.1.2 Portable CT Scanners

3 Technology

  • 3.1 Overview
    • 3.1.1 High-Slice CT
    • 3.1.2 Mid-Slice CT
    • 3.1.3 Low-Slice CT
    • 3.1.4 Cone Beam CT (CBCT)

4 End User

  • 4.1 Overview
    • 4.1.1 Hospitals and Ambulatory Surgical Centers
    • 4.1.2 Diagnostic Centers
    • 4.1.3 Others

5 Region

  • 5.1 Regional Summary
  • 5.2 North America
    • 5.2.1 Regional Overview
    • 5.2.2 Driving Factors for Market Growth
    • 5.2.3 Factors Challenging the Market
    • 5.2.4 Market Sizing and Forecast
    • 5.2.5 U.S.
      • 5.2.5.1 Country Overview
      • 5.2.5.2 Market Sizing and Forecast
    • 5.2.6 Canada
      • 5.2.6.1 Country Overview
      • 5.2.6.2 Market Sizing and Forecast
  • 5.3 Europe
    • 5.3.1 Regional Overview
    • 5.3.2 Driving Factors for Market Growth
    • 5.3.3 Factors Challenging the Market
    • 5.3.4 Market Sizing and Forecast
    • 5.3.5 U.K.
      • 5.3.5.1 Country Overview
      • 5.3.5.2 Market Sizing and Forecast
    • 5.3.6 Germany
      • 5.3.6.1 Country Overview
      • 5.3.6.2 Market Sizing and Forecast
    • 5.3.7 France
      • 5.3.7.1 Country Overview
      • 5.3.7.2 Market Sizing and Forecast
    • 5.3.8 Italy
      • 5.3.8.1 Country Overview
      • 5.3.8.2 Market Sizing and Forecast
    • 5.3.9 Spain
      • 5.3.9.1 Country Overview
      • 5.3.9.2 Market Sizing and Forecast
    • 5.3.10 Rest-of-the- Europe
      • 5.3.10.1 Country Overview
      • 5.3.10.2 Market Sizing and Forecast
  • 5.4 Asia Pacific
    • 5.4.1 Regional Overview
    • 5.4.2 Driving Factors for Market Growth
    • 5.4.3 Factors Challenging the Market
    • 5.4.4 Market Sizing and Forecast
    • 5.4.5 China
      • 5.4.5.1 Country Overview
      • 5.4.5.2 Market Sizing and Forecast
    • 5.4.6 Japan
      • 5.4.6.1 Country Overview
      • 5.4.6.2 Market Sizing and Forecast
    • 5.4.7 India
      • 5.4.7.1 Country Overview
      • 5.4.7.2 Market Sizing and Forecast
    • 5.4.8 Australia
      • 5.4.8.1 Country Overview
      • 5.4.8.2 Market Sizing and Forecast
    • 5.4.9 South Korea
      • 5.4.9.1 Country Overview
      • 5.4.9.2 Market Sizing and Forecast
    • 5.4.10 Rest-of-the-Asia Pacific
      • 5.4.10.1 Country Overview
      • 5.4.10.2 Market Sizing and Forecast
  • 5.5 Latin America
    • 5.5.1 Regional Overview
    • 5.5.2 Driving Factors for Market Growth
    • 5.5.3 Factors Challenging the Market
    • 5.5.4 Market Sizing and Forecast
    • 5.5.5 Brazil
      • 5.5.5.1 Country Overview
      • 5.5.5.2 Market Sizing and Forecast
    • 5.5.6 Mexico
      • 5.5.6.1 Country Overview
      • 5.5.6.2 Market Sizing and Forecast
    • 5.5.7 Rest-of-Latin America
      • 5.5.7.1 Country Overview
      • 5.5.7.2 Market Sizing and Forecast
  • 5.6 Middle East and Africa
    • 5.6.1 Regional Overview
    • 5.6.2 Driving Factors for Market Growth
    • 5.6.3 Factors Challenging the Market
    • 5.6.4 Market Sizing and Forecast
    • 5.6.5 Turkey
      • 5.6.5.1 Country Overview
      • 5.6.5.2 Market Sizing and Forecast
    • 5.6.6 Israel
      • 5.6.6.1 Country Overview
      • 5.6.6.2 Market Sizing and Forecast
    • 5.6.7 Rest-of-Middle East and Africa
      • 5.6.7.1 Country Overview
      • 5.6.7.2 Market Sizing and Forecast

6 Competitive Benchmarking and Company Profiles

  • 6.1 Key Strategies and Developments, 2020-2026
  • 6.2 Key Developments Analysis (by Company), 2024-2026
  • 6.3 Company Profiles
    • 6.3.1 Canon Inc.
      • 6.3.1.1 Overview
    • 6.3.2 Carestream Health
      • 6.3.2.1 Overview
    • 6.3.3 Siemens Healthineers AG
      • 6.3.3.1 Overview
    • 6.3.4 GE HealthCare
      • 6.3.4.1 Overview
    • 6.3.5 FUJIFILM Corporation
      • 6.3.5.1 Overview
    • 6.3.6 Koninklijke Philips N.V.
      • 6.3.6.1 Overview
    • 6.3.7 Koning Health
      • 6.3.7.1 Overview
    • 6.3.8 NeuroLogica Corp.
      • 6.3.8.1 Overview
    • 6.3.9 Neusoft Corporation
      • 6.3.9.1 Overview
    • 6.3.10 Shenzhen Anke High-tech Co., Ltd
      • 6.3.10.1 Overview
    • 6.3.11 Shanghai United Imaging Healthcare Co., Ltd.
      • 6.3.11.1 Overview
    • 6.3.12 Planmed Oy
      • 6.3.12.1 Overview
    • 6.3.13 VATECH
      • 6.3.13.1 Overview
    • 6.3.14 Xoran Technologies
      • 6.3.14.1 Overview

7 Research Methodology

  • 7.1 Data Sources
    • 7.1.1 Primary Data Sources
    • 7.1.2 Secondary Data Sources
    • 7.1.3 Data Triangulation
  • 7.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Computed Tomography Market (by Scenario), $Million, 2025, 2026, and 2036
  • Figure 2: Global Computed Tomography Market, 2025 and 2036
  • Figure 3: Global Computed Tomography Market (by Country), $Million, 2025
  • Figure 4: Global Computed Tomography Market Snapshot
  • Figure 5: Global Computed Tomography Market, $Million, 2025 and 2036
  • Figure 6: Computed Tomography Market (by Type), $Million, 2025, 2030, and 2036
  • Figure 7: Computed Tomography Market (by Technology), $Million, 2025, 2030, and 2036
  • Figure 8: Computed Tomography Market (by End User), $Million, 2025, 2030, and 2036
  • Figure 9: Computed Tomography Market Segmentation
  • Figure 10: Supply Chain and Risks within the Supply Chain
  • Figure 11: Global Computed Tomography Market, Value Chain Analysis
  • Figure 12: Global Computed Tomography Market (by Type), $Million, 2025, 2030, and 2036
  • Figure 13: Global Computed Tomography Market (Stationary CT Scanners), $Million, 2024-2036
  • Figure 14: Global Computed Tomography Market (Portable CT Scanners), $Million, 2024-2036
  • Figure 15: Global Computed Tomography Market (by Technology), $Million, 2025, 2030, and 2036
  • Figure 16: Global Computed Tomography Market (High-Slice CT), $Million, 2024-2036
  • Figure 17: Global Computed Tomography Market (Mid-Slice CT), $Million, 2024-2036
  • Figure 18: Global Computed Tomography Market (Low-Slice CT), $Million, 2024-2036
  • Figure 19: Global Computed Tomography Market (Cone Beam CT), $Million, 2024-2036
  • Figure 20: Global Computed Tomography Market (by End User), $Million, 2025, 2030, and 2036
  • Figure 21: Global Computed Tomography Market (Hospitals and Ambulatory Surgical Centers), $Million, 2024-2036
  • Figure 22: Global Computed Tomography Market (Diagnostic Centers), $Million, 2024-2036
  • Figure 23: Global Computed Tomography Market (Others), $Million, 2024-2036
  • Figure 24: North America Computed Tomography Market, $Million, 2024-2036
  • Figure 25: U.S. Computed Tomography Market, $Million, 2024-2036
  • Figure 26: Canada Computed Tomography Market, $Million, 2024-2036
  • Figure 27: Europe Computed Tomography Market, $Million, 2024-2036
  • Figure 28: U.K. Computed Tomography Market, $Million, 2024-2036
  • Figure 29: Germany Computed Tomography Market, $Million, 2024-2036
  • Figure 30: France Computed Tomography Market, $Million, 2024-2036
  • Figure 31: Italy Computed Tomography Market, $Million, 2024-2036
  • Figure 32: Spain Computed Tomography Market, $Million, 2024-2036
  • Figure 33: Rest-of-Europe Computed Tomography Market, $Million, 2024-2036
  • Figure 34: Asia-Pacific Computed Tomography Market, $Million, 2024-2036
  • Figure 35: China Computed Tomography Market, $Million, 2024-2036
  • Figure 36: Japan Computed Tomography Market, $Million, 2024-2036
  • Figure 37: India Computed Tomography Market, $Million, 2024-2036
  • Figure 38: Australia Computed Tomography Market, $Million, 2024-2036
  • Figure 39: South Korea Computed Tomography Market, $Million, 2024-2036
  • Figure 40: Rest-of-Asia-Pacific Computed Tomography Market, $Million, 2024-2036
  • Figure 41: Latin America Computed Tomography Market, $Million, 2024-2036
  • Figure 42: Brazil Computed Tomography Market, $Million, 2024-2036
  • Figure 43: Mexico Computed Tomography Market, $Million, 2024-2036
  • Figure 44: Rest-of-Latin America Computed Tomography Market, $Million, 2024-2036
  • Figure 45: Middle East and Africa Computed Tomography Market, $Million, 2024-2036
  • Figure 46: Turkey Computed Tomography Market, $Million, 2024-2036
  • Figure 47: Israel Computed Tomography Market, $Million, 2024-2036
  • Figure 48: Rest-of-Middle East and Africa Computed Tomography Market, $Million, 2024-2036
  • Figure 49: Key Strategies and Developments, 2020-2026
  • Figure 50: Data Triangulation
  • Figure 51: Top-Down and Bottom-Up Approach
  • Figure 52: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global Computed Tomography Market, Regulatory Approvals
  • Table 3: Global Computed Tomography Market, Strategic Partnerships and Alliances
  • Table 4: Computed Tomography Scanner Density (by Country), 2023 or Nearest Year (per million population)
  • Table 5: Photon-Counting CT (PCCT) Systems: Approval and Commercialization Status (2026)
  • Table 6: CT Scanner Pricing by System Configuration (New Systems)
  • Table 7: Global Computed Tomography Market (by Region), $Million, 2024-2036
  • Table 8: Global Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 9: Global Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 10: Global Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 11: North America Computed Tomography Market (by Country), $Million, 2024-2036
  • Table 12: North America Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 13: North America Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 14: North America Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 15: U.S. Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 16: U.S. Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 17: U.S. Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 18: Canada Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 19: Canada Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 20: Canada Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 21: Europe Computed Tomography Market (by Country), $Million, 2024-2036
  • Table 22: Europe Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 23: Europe Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 24: Europe Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 25: U.K. Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 26: U.K. Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 27: U.K. Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 28: Germany Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 29: Germany Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 30: Germany Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 31: France Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 32: France Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 33: France Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 34: Italy Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 35: Italy Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 36: Italy Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 37: Spain Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 38: Spain Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 39: Spain Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 40: Rest-of-Europe Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 41: Rest-of-Europe Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 42: Rest-of-Europe Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 43: Asia-Pacific Computed Tomography Market (by Country), $Million, 2024-2036
  • Table 44: Asia-Pacific Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 45: Asia-Pacific Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 46: Asia-Pacific Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 47: China Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 48: China Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 49: China Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 50: Japan Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 51: Japan Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 52: Japan Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 53: India Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 54: India Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 55: India Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 56: Australia Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 57: Australia Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 58: Australia Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 59: South Korea Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 60: South Korea Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 61: South Korea Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 62: Rest-of-Asia-Pacific Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 63: Rest-of-Asia-Pacific Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 64: Rest-of-Asia-Pacific Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 65: Latin America Computed Tomography Market (by Country), $Million, 2024-2036
  • Table 66: Latin America Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 67: Latin America Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 68: Latin America Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 69: Brazil Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 70: Brazil Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 71: Brazil Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 72: Mexico Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 73: Mexico Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 74: Mexico Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 75: Rest-of-Latin America Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 76: Rest-of-Latin America Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 77: Rest-of-Latin America Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 78: Middle East and Africa Computed Tomography Market (by Country), $Million, 2024-2036
  • Table 79: Middle East and Africa Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 80: Middle East and Africa Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 81: Middle East and Africa Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 82: Turkey Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 83: Turkey Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 84: Turkey Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 85: Israel Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 86: Israel Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 87: Israel Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 88: Rest-of-Middle East and Africa Computed Tomography Market (by Type), $Million, 2024-2036
  • Table 89: Rest-of-Middle East and Africa Computed Tomography Market (by Technology), $Million, 2024-2036
  • Table 90: Rest-of-Middle East and Africa Computed Tomography Market (by End User), $Million, 2024-2036
  • Table 91: Key Strategies and Developments, 2024-2026